Research Articles

Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G

A 50% infectious dose (ID50) of 132 Cryptosporidium parvum oocysts was previously determined in serologically negative individuals (ELISA). In this study, 17 healthy adults with pre-existing anti-C. parvum serum IgG were challenged with 500-50,000 oocysts. Infection and diarrhea were associated with the higher challenge doses. The ID50 was 1,880 oocysts, > 20-fold higher than in seronegative volunteers. Fecal oocysts were detected in only seven (53.8%) of 13 individuals with clinical cryptosporidiosis, indicating that the host response may effectively decrease the number of oocysts produced. Subjects with the highest absorbances prior to challenge had little to no increase in IgG following challenge, whereas volunteers with lower reactivities showed significant postchallenge increases. This suggests that an upper limit of serum IgG was present in some subjects, while others were further stimulated by an additional exposure. These data indicate that prior exposure to C. parvum provides protection from infection and illness at low oocyst doses.

This article has been cited by other articles:

				A P Davies and R M Chalmers Cryptosporidiosis BMJ, October 19, 2009; 339(oct19_1): b4168 - b4168. [Full Text]

				J. Liu, S. Enomoto, C. A. Lancto, M. S. Abrahamsen, and M. S. Rutherford Inhibition of Apoptosis in Cryptosporidium parvum-Infected Intestinal Epithelial Cells Is Dependent on Survivin Infect. Immun., August 1, 2008; 76(8): 3784 - 3792. [Abstract] [Full Text] [PDF]

				C. L. CHAPPELL, P. C. OKHUYSEN, R. LANGER-CURRY, G. WIDMER, D. E. AKIYOSHI, S. TANRIVERDI, and S. TZIPORI CRYPTOSPORIDIUM HOMINIS: EXPERIMENTAL CHALLENGE OF HEALTHY ADULTS Am J Trop Med Hyg, November 1, 2006; 75(5): 851 - 857. [Abstract] [Full Text] [PDF]

				C. S. ONG, A. S. LI, J. W. PRIEST, R. COPES, M. KHAN, M. W. FYFE, S. A. MARION, J. M. ROBERTS, P. J. LAMMIE, and J. L. ISAAC-RENTON ENZYME IMMUNOASSAY OF CRYPTOSPORIDIUM-SPECIFIC IMMUNOGLOBULIN G ANTIBODIES TO ASSESS LONGITUDINAL INFECTION TRENDS IN SIX COMMUNITIES IN BRITISH COLUMBIA, CANADA Am J Trop Med Hyg, August 1, 2005; 73(2): 288 - 295. [Abstract] [Full Text] [PDF]

				S. A. Kjos, M. Jenkins, P. C. Okhuysen, and C. L. Chappell Evaluation of Recombinant Oocyst Protein CP41 for Detection of Cryptosporidium-Specific Antibodies Clin. Vaccine Immunol., February 1, 2005; 12(2): 268 - 272. [Abstract] [Full Text] [PDF]

				J. N. S. Eisenberg, X. Lei, A. H. Hubbard, M. A. Brookhart, and J. M. Colford Jr. The Role of Disease Transmission and Conferred Immunity in Outbreaks: Analysis of the 1993 Cryptosporidium Outbreak in Milwaukee, Wisconsin Am. J. Epidemiol., January 1, 2005; 161(1): 62 - 72. [Abstract] [Full Text] [PDF]

				M. T. Katanik, S. K. Schneider, J. E. Rosenblatt, G. S. Hall, and G. W. Procop Evaluation of ColorPAC Giardia/Cryptosporidium Rapid Assay and ProSpecT Giardia/Cryptosporidium Microplate Assay for Detection of Giardia and Cryptosporidium in Fecal Specimens J. Clin. Microbiol., December 1, 2001; 39(12): 4523 - 4525. [Abstract] [Full Text] [PDF]

				T. B. Muller, F. J. Frost, G. F. Craun, R. L. Calderon, C. L. Chappell, P. C. Okhuysen, and S. M. Dann Serological Responses to Cryptosporidium Infection Infect. Immun., March 1, 2001; 69(3): 1974 - 1975. [Full Text] [PDF]

				P. Robinson, P. C. Okhuysen, C. L. Chappell, D. E. Lewis, I. Shahab, A. Janecki, and A. C. White Jr. Expression of Tumor Necrosis Factor Alpha and Interleukin 1{beta} in Jejuna of Volunteers after Experimental Challenge with Cryptosporidium parvum Correlates with Exposure but Not with Symptoms Infect. Immun., February 1, 2001; 69(2): 1172 - 1174. [Abstract] [Full Text] [PDF]

				G. Robin, D. Fraser, N. Orr, T. Sela, R. Slepon, R. Ambar, R. Dagan, S. Le Blancq, R. J. Deckelbaum, and D. Cohen Cryptosporidium Infection in Bedouin Infants Assessed by Prospective Evaluation of Anticryptosporidial Antibodies and Stool Examination Am. J. Epidemiol., January 15, 2001; 153(2): 194 - 201. [Abstract] [Full Text] [PDF]

				P. Robinson, P. C. Okhuysen, C. L. Chappell, D. E. Lewis, I. Shahab, S. Lahoti, and A. C. White Jr. Transforming Growth Factor beta 1 Is Expressed in the Jejunum after Experimental Cryptosporidium parvum Infection in Humans Infect. Immun., September 1, 2000; 68(9): 5405 - 5407. [Abstract] [Full Text] [PDF]

				L. S. Garcia, R. Y. Shimizu, and C. N. Bernard Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum Antigens in Human Fecal Specimens Using the Triage Parasite Panel Enzyme Immunoassay J. Clin. Microbiol., September 1, 2000; 38(9): 3337 - 3340. [Abstract] [Full Text]

				L. S. Garcia and R. Y. Shimizu Detection of Giardia lamblia and Cryptosporidium parvum Antigens in Human Fecal Specimens Using the ColorPAC Combination Rapid Solid-Phase Qualitative Immunochromatographic Assay J. Clin. Microbiol., March 1, 2000; 38(3): 1267 - 1268. [Abstract] [Full Text]